Chronic alcoholics[scquote] (CA) knowledge (KN) and social stigmatisation (ST) regarding tuberculosis (TB) Source: Eur Respir J 2001; 18: Suppl. 33, 322s Year: 2001
Late Breaking Abstract - Tocilizumab (T) plus pembrolizumab (P) in patients (pts) with Covid-19 pneumonia: COPERNICO Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021
Hospitalisation costs for community-acquired pneumonia (CAP) in France (F), Germany (D), Japan (J) and USA Source: Eur Respir J 2004; 24: Suppl. 48, 8s Year: 2004
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Tuberculosis (TB) relapse rate among patients treated with moxifloxacin (m) or ethambutol (E) in the intensive phase of therapy Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009
The impact of antimicrobial resistance on the cost-effectiveness of empirical treatment of community-acquired pneumonia (CAP) in France (FR), Belgium (BE) and Germany (DE) Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Asthma control in Latin america (LA) and Caribbean (CAR) countries: correlation between asthma control test (ACT), FEV1 and current treatment Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009
Accuracy of EGFR and K-Ras mutation detection in non small cell lung carcinoma: Ring trial in 15 molecular French laboratories (ERMETIC project – Part 1) Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010
Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
A retrospective study of the indications for the use of interferon gamma release assays (IGRA) in a United Kingdom (UK) district general hospital (DGH) tuberculosis (TB) clinic Source: International Congress 2015 – Screening strategies in TB Year: 2015
Tuberculosis (TB), mortality - efficiency of new control / treatment strategies Source: Annual Congress 2003 - Control of tuberculosis Year: 2003
Effect of resistance training (RT) on maximal exercise capacity (MEC) and muscle force (MF) in patients (pts) with radically treated (RaT) intrathoracic cancer Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013
Clinical pattern of extrapulmonary tuberculosis (EPT) as observed at a teaching hospital in India – are we missing them? Source: Annual Congress 2009 - Pulmonary infections Year: 2009
Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Patients with culture positive active tuberculosis but negative "QuantiFERON-TB Gold in Tube Test" (QFT) – A critical view on the cut-off in clinical praxis Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010
Doctors (drs) knowledge of diagnosing, investigating & managing pulmonary embolus (PE) in pregnancy? Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia) Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB) Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Afatinib (A) vs gefitinib (G) as first-line treatment (tx) for patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: LUX-Lung 7 Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016